Distal Bypass Versus Infrageniculate Endovascular Intervention for Chronic Limb-Threatening Ischemia.


Journal

Vascular and endovascular surgery
ISSN: 1938-9116
Titre abrégé: Vasc Endovascular Surg
Pays: United States
ID NLM: 101136421

Informations de publication

Date de publication:
Jul 2022
Historique:
pubmed: 1 4 2022
medline: 7 6 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Chronic limb-threatening ischemia (CLTI) carries a high risk of amputation and warrants urgent intervention. CLTI involving the infrageniculate vessels, in particular, carries a considerably higher risk of major limb amputation. Open surgical bypass is the historical gold standard for the treatment of tibial arterial disease; however, endovascular therapy provides an attractive alternative in this high-risk patient population. In this article, we review the existing literature regarding distal bypass and infrageniculate endovascular intervention in patients with CLTI.

Identifiants

pubmed: 35356834
doi: 10.1177/15385744221086347
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

539-544

Auteurs

Young Kim (Y)

Division of Vascular and Endovascular Surgery, Harvard Medical School, 548305Massachusetts General Hospital, Boston, MA. USA.

Charles S Decarlo (CS)

Division of Vascular and Endovascular Surgery, Harvard Medical School, 548305Massachusetts General Hospital, Boston, MA. USA.

Karthik Thangappan (K)

Division of Vascular and Endovascular Surgery, Harvard Medical School, 548305Massachusetts General Hospital, Boston, MA. USA.

Nikolaos Zacharias (N)

Division of Vascular and Endovascular Surgery, Harvard Medical School, 548305Massachusetts General Hospital, Boston, MA. USA.

Abhisekh Mohapatra (A)

Division of Vascular and Endovascular Surgery, Harvard Medical School, 548305Massachusetts General Hospital, Boston, MA. USA.

Anahita Dua (A)

Division of Vascular and Endovascular Surgery, Harvard Medical School, 548305Massachusetts General Hospital, Boston, MA. USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH